Amgen is investing more than $600 million to construct a new science and innovation centre at its global headquarters in Thousand Oaks, California1345.
The facility will integrate advanced automation and digital capabilities and is designed to expedite the development of new therapeutics for serious diseases13.
The centre aims to foster collaboration among engineers, scientists, and researchers from multiple disciplines to accelerate scientific breakthroughs in biotechnology1.
Construction of the centre is scheduled to begin in the third quarter of 2025 and is expected to create hundreds of jobs13.
Amgen cites renewed US corporate tax incentives as instrumental in enabling this large domestic investment13.
This move follows other substantial investments by Amgen, such as a $900 million expansion in Ohio and a $1 billion manufacturing facility in North Carolina13.
The new centre is intended to enhance Amgen's global network and further its operational and technological expertise1.
Sources:
1. https://www.pharmaceutical-technology.com/news/amgen-science-and-innovation-hub/
3. https://www.biopharmadive.com/news/amgen-new-center-replimune-fda-meeting-sanofi-wayrilz/758944/